The collaboration between ten23 health and BD aims to commercialize the BD Libertas wearable injector for large-volume ...
Balch’s perspective underscores the broader affordability crisis facing working families and highlights how rising premiums ...
In today’s Pharma Pulse, the FDA and EMA synchronize on AI standards, a potential divide in pricing strategy occurs, and ...
Oral semaglutide was approved by the FDA in December 2025 as a once-daily pill (25 mg), intended to limit excess body weight ...
According to Alan Balch, PhD, CEO of the Patient Advocate Foundation and the National Patient Advocate Foundation, rising ...
In today’s Pharma Pulse, Novartis calls for a shift from "cost-containment" to structural reform, hospital mergers hit their ...
Dawsongroup tcs USA has officially launched in the United States, and in the process, is introducing its modular cold chain ...
Balch’s perspective underscores the broader affordability crisis facing working families and highlights how rising premiums ...
In today’s Pharma Pulse, President Trump unveils a patient payment plan, the FDA flags a rare seizure risk for several ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback